Toby Eyre: Important primary analysis of UK MCL biobank at EHA2024

Toby Eyre, CLL specialist at Oxford University Hospitals, shared on X:

“Look out for important primary analysis of UK MCL biobank at EHA2024.

Mant et al N=588, Active observation in 38% (N=222) of prospectively identified MCL patients.

Delaying initiation of treatment in indolent Mantel Cell Lymphoma does not worsen survival outcomes versus immediate treatment.

Valid management strategy.”

Source: Toby Eyre/X